ICU MEDICAL INC/DE Revenue from Contract with Customer, Excluding Assessed Tax
ICU MEDICAL INC/DE (ICUI) reported Revenue from Contract with Customer, Excluding Assessed Tax of $551.68 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- ICU MEDICAL INC/DE revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $551.68M, a 0.51% increase year-over-year.
- ICU MEDICAL INC/DE revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $530.23M, a 12.32% decline year-over-year.
- ICU MEDICAL INC/DE revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $536.99M, a 8.85% decline year-over-year.
- ICU MEDICAL INC/DE revenue from contract with customer, excluding assessed tax for the quarter ending 2025-06-30 was $548.87M, a 7.98% decline year-over-year.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month |
|---|---|---|---|
| 2026-06-30 | $551.68M 10-Q · filed 2026-08-06 | $1.08B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $530.23M 10-Q · filed 2026-05-07 | ||
| 2025-09-30 | $536.99M 10-Q · filed 2025-11-06 | $1.09B derived: sum of 2 quarters · filed 2026-08-06 | $1.69B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $548.87M 10-Q · filed 2026-08-06 | $1.15B 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $604.70M 10-Q · filed 2026-05-07 | ||
| 2024-09-30 | $589.13M 10-Q · filed 2025-11-06 | $1.19B derived: sum of 2 quarters · filed 2025-11-06 | $1.75B 10-Q · filed 2025-11-06 |
| 2024-06-30 | $596.46M 10-Q · filed 2025-08-07 | $1.16B 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $566.65M 10-Q · filed 2025-05-08 | ||
| 2023-09-30 | $553.31M 10-Q · filed 2024-11-12 | $1.10B derived: sum of 2 quarters · filed 2024-11-12 | $1.67B 10-Q · filed 2024-11-12 |
| 2023-06-30 | $549.31M 10-Q · filed 2024-08-07 | $1.12B 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $568.65M 10-Q · filed 2024-05-07 | ||
| 2022-09-30 | $597.86M 10-Q · filed 2023-11-06 | $1.16B derived: sum of 2 quarters · filed 2023-11-06 | $1.70B 10-Q · filed 2023-11-06 |
| 2022-06-30 | $561.00M 10-Q · filed 2023-08-07 | $1.10B 10-Q · filed 2023-08-07 | |
| 2022-03-31 | $543.12M 10-Q · filed 2023-05-09 | ||
| 2021-09-30 | $336.06M 10-Q · filed 2022-11-07 | $657.74M derived: sum of 2 quarters · filed 2022-11-07 | $975.78M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $321.68M 10-Q · filed 2022-08-09 | $639.72M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $318.05M 10-Q · filed 2022-05-09 | ||
| 2020-09-30 | $318.57M 10-Q · filed 2021-11-05 | $621.95M derived: sum of 2 quarters · filed 2021-11-05 | $950.55M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $303.38M 10-Q · filed 2021-08-04 | $631.99M 10-Q · filed 2021-08-04 | |
| 2020-03-31 | $328.61M 10-Q · filed 2021-05-07 | ||
| 2019-09-30 | $307.47M 10-Q · filed 2020-11-06 | $619.75M derived: sum of 2 quarters · filed 2020-11-06 | $950.68M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $312.28M 10-Q · filed 2020-08-10 | $643.21M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $330.93M 10-Q · filed 2020-05-08 | ||
| 2018-09-30 | $327.17M 10-Q · filed 2019-11-12 | $687.63M derived: sum of 2 quarters · filed 2019-11-12 | $1.06B 10-Q · filed 2019-11-12 |
| 2018-06-30 | $360.46M 10-Q · filed 2019-08-09 | $732.49M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $372.03M 10-Q · filed 2019-05-10 | ||
| 2017-09-30 | $343.24M 10-Q · filed 2018-11-09 | $922.49M 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |